Holen Sie sich die Stockscreener-App
1.04
2.80%
-0.03
Handel nachbörslich:
1.03
-0.01
-0.96%
Schlusskurs vom Vortag:
$1.07
Offen:
$1.08
24-Stunden-Volumen:
3.73M
Relative Volume:
0.38
Marktkapitalisierung:
$439.73M
Einnahmen:
$199.30M
Nettoeinkommen (Verlust:
$-230.47M
KGV:
-0.8068
EPS:
-1.2891
Netto-Cashflow:
$-58.89M
1W Leistung:
+0.00%
1M Leistung:
-24.64%
6M Leistung:
-6.31%
1J Leistung:
-46.11%
1-Tages-Spanne:
$1.04
$1.085
1-Wochen-Bereich:
$0.956
$1.09
52-Wochen-Spanne:
$0.8435
$2.38
Canopy Growth Corporation Stock (CGC) Company Profile
Firmenname
Canopy Growth Corporation
Sektor
Telefon
855-558-9333
Adresse
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.04 | 452.42M | 199.30M | -230.47M | -58.89M | -1.2891 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-11-10 | Hochstufung | The Benchmark Company | Sell → Hold |
| 2023-04-04 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-11-02 | Eingeleitet | Bernstein | Underperform |
| 2022-10-26 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-03-22 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-12-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-12-20 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-12-07 | Eingeleitet | Wells Fargo | Underweight |
| 2021-11-18 | Eingeleitet | Barclays | Equal Weight |
| 2021-11-08 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-11-08 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-11-08 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-10-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-08-12 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-06-02 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2021-05-25 | Hochstufung | MKM Partners | Neutral → Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-24 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-02-10 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-02-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-02-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-04 | Hochstufung | CFRA | Buy → Strong Buy |
| 2020-06-01 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-06-01 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-06-01 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2020-06-01 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-01 | Herabstufung | Stifel | Buy → Sell |
| 2020-05-22 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-04-16 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-01-28 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-12-12 | Bestätigt | Cantor Fitzgerald | Neutral |
| 2019-11-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-15 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-14 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2019-10-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2019-09-27 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-09-18 | Eingeleitet | Oppenheimer | Perform |
| 2019-08-26 | Hochstufung | Seaport Global Securities | Neutral → Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Canopy Growth Corporation Aktie (CGC) Neueste Nachrichten
Should you buy CGC stock after marijuana reclassification? - MSN
Why Is Canopy Growth Facing Fresh Cannabis Market Pressure? - Kalkine Media
Top Cannabidiol (CBD) Companies Driving Market Growth - SNS Insider
Canopy Growth's stock just dropped -- here's why I'm still not buying - MSN
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now - Yahoo Finance
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now - The Motley Fool
Canopy Growth Corporation (CGC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Should You Buy CGC Stock After Marijuana Reclassification? - Zacks Investment Research
StockTalk | Cannabis Report: Quarterly reporting season rolls on | 2026-05-22 | Investing News - Stockhouse
CGC Stock Chart | CANOPY GROWTH CORP (NASDAQ:CGC) - ChartMill
Canopy Growth stock edges up with oversold signals limiting fresh declines - Traders Union
Canopy Growth's Stock Just Dropped -- Here's Why I'm Still Not Buying - The Motley Fool
WEED.CA Stock Price, Quote & Chart | CANOPY GROWTH CORP (TSX:WEED) - ChartMill
Buying pressure lifts Canopy Growth stock higher in today's trading - Traders Union
Canopy Growth stock price forecast: $1.23 resistance in focus as CGC advances 6.08% - Traders Union
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Canopy Growth Shares Fall After Disclosing Accounting Error, Plans Restatement of FY24, FY25 Results - Moomoo
Selling pressure pushes Canopy Growth stock lower in today's trading - Traders Union
Canopy Growth Moves Into Spotlight Amid Filing Revisions - Kalkine Media
Cannabis Stocks Today — 19 May 2026: Trulieve at $8.02 - Business of Cannabis
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today - MSN
Canopy Growth CorporationCommon Shares (NQ: CGC - The Chronicle-Journal
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth - Yahoo Finance UK
Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026 - marketscreener.com
Canopy Growth jumps as US moves to ease medical marijuana restrictions - MSN
Should Canopy Growth stock be in your portfolio post Q3 earnings? - MSN
Canopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 Months - AOL.com
What's going on with Canopy Growth stock Thursday? - MSN
Canopy Growth to Restate Financials for 2024 and 2025 Due to Non-Cash Accounting Error; 2026 Results Coming June 15, 2026 - Minichart
Drake Launches Cannabis Company More Life - revolt.tv
Canopy Growth Says During YE Financial Reporting Process For Fiscal Year Ended March 31, 2026, the Co Identified a Technical Non-cash Accounting Error - Moomoo
Canopy Growth Also Plans to File Restated Financials for Fiscal Years Ended March 31, 2025 and March 31, 2024 and Certain Interim Periods - Moomoo
Canopy Growth Expects to Release Financial Results for Quarter and Fiscal Year Ended March 31, 2026, Before Markets Open on June 15, 2026 - Moomoo
Canopy Growth flags accounting error, will redo two years of results - Stock Titan
Is Canopy Growth Stock Finally Setting Up for a Real Turnaround? - Yahoo Finance
Canopy Growth stock falls as short-term selling outweighs buyers near crucial support - Traders Union
Europe’s Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets - marketscreener.com
Canopy Growth is one of the market's most polarizing stocks: 3 scenarios for the next 12 months - MSN
Cannabis Stocks Today — Wednesday 13 May 2026: Organigram Slides to $1.11 as Sector Posts Broad Losses - Business of Cannabis
Canopy Growth Corporation (CGC) registers a bigger fall than the market: Important facts to note - MSN
Should I Buy CGC (Canopy Growth Corporation) | AI Analysis, Technical & News Insights - Kavout
Canopy Growth Corporation (CGC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights - MSN
+3.15% for Canopy Growth stock as recent selling eases ahead of resistance - Traders Union
CGC Stock Price, Quote & Chart | CANOPY GROWTH CORP (NASDAQ:CGC) - ChartMill
Best Cannabis Stocks To Follow TodayMay 10th - MarketBeat
Cannabis Stocks To ResearchMay 9th - MarketBeat
Finanzdaten der Canopy Growth Corporation-Aktie (CGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.92%
4.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):